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background:  Black Americans suffer disproportionately from hypertensive heart disease but expert panels debate the goal of 
antihypertensive therapy, i.e., the level of clinic blood pressure (BP) that needs to be achieved in order to eliminate this disparity. Because 
clinic BP is so prone to both over-estimation and under-estimation of patients’ typical BP in their daily lives, we hypothesized that home 
BP is more representative of daily left ventricular pressure overload and thus constitutes a more potent determinant of left ventricular 
hypertrophy (LVH).
Methods:  We analyzed cross-sectional data from 1,262 non-Hispanic black and 927 non-Hispanic white adults ages 30-64 years who 
underwent both multiple home BP and clinic BP measurements with the same validated oscillometric BP monitor and cardiac magnetic 
resonance imaging to test for LVH in the Dallas Heart Study, a population-based probability sample.
Results:  LVH, as expected, was far more common among black than white adults, in both untreated subjects (13% vs. 4%, p<0.001) and 
treated hypertensives (31% vs. 17%, p<.001). In multivariate logistic regression that accounted for conventional determinants of LVH_clinic 
systolic BP, age, and smoking_for each 10 mmHg increase in home systolic BP above 110 mmHg, the probability of LVH increased by 
46% in untreated black subjects (adjusted odds ratio, aOR 1.46; 95% confidence interval, CI: 1.24-1.73, P<0.001) and by 52% (aOR 1.52; 
95% CI, 1.31-1.76, P<0.001) in treated black hypertensives. After adjusting for home systolic BP, increased clinic systolic BP remained a 
determinant of LVH in untreated black subjects (aOR 1.28; 95% CI, 1.09-1.51, P<0.03) but was no longer a determinant of LVH in treated 
black hypertensives (aOR 1.06; 95% CI, 0.91-1.24, p=0.4). Similar trends were observed in whites.
conclusion: These observational data demonstrate the superiority of home versus clinic blood pressure as a determinant of LVH in a 
high-risk contemporary urban black population. Strict reliance on conventional clinic BP by hypertension guidelines panels may perpetuate 
under-treatment of daily pressure overload and thus missed opportunities to prevent hypertensive heart disease in black patients.
